Sensorion receives ANSM authorization to start SENS-601 trial in France
Sensorion said the ANSM has authorized it to initiate its Hear… clinical trial in France for SENS-601, its investigational gene therapy for GJB2-related hearing loss.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.